![Markus Jensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Jensen
Chief Tech/Sci/R&D Officer at
INNATE PHARMA
Profile
Markus Jensen is currently Chief Medical Officer at Innate Pharma SA, starting in 2026.
Mr. Jensen holds a doctorate from Universität zu Köln.
Markus Jensen active positions
| Companies | Position | Start |
|---|---|---|
| INNATE PHARMA | Chief Tech/Sci/R&D Officer | 2026-08-31 |
Training of Markus Jensen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
- Stock Market
- Insiders
- Markus Jensen
